Hill-Rom Hlds

Hill-Rom Holdings, Inc. operates as a medical technology company. The firm focuses on patient care solutions that improve clinical and economic outcomes. It operates through the following segments: Patient Support System, Front Line Care and Surgical Solutions. The Patient Support Systems segment provides bed frames and surfaces, mobility and clinical workflow solutions. The Front Line Care segment offers respiratory care products and sells medical diagnostic equipment and a diversified portfolio of devices. The Surgical Solutions segment supplies surgical products including tables, lights, pendants, positioning devices, various other surgical products and accessories. The company was founded by William A. Hillenbrand on August 7, 1969 and is headquartered in Chicago, IL.

CHICAGO, July 20, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today it is Advancing Connected Care™ in the operating room (OR) with the launch of its Helion™ Integrated Surgical System in the U.S. market. The Helion System provides surgical teams with the operating room connectivity, flexibility and efficient staff communications they need to enhance patient outcomes.

Hillrom Announces Connected Care Solution For The Operating Room With U.S. Launch Of Helion™ Integrated Surgical System

Surmodics

HRC vs. SRDX: Which Stock Is the Better Value Option?

HRC vs. SRDX: Which Stock Should Value Investors Buy Now?

CHICAGO, July 12, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that the Delaware Court of Chancery ordered Hillrom to proceed with its proposed acquisition of Bardy Diagnostics, Inc. (BardyDx), denying Hillrom's claim of a Material Adverse Event under the terms of the acquisition agreement executed by the companies on January 15, 2021. HillromThe company intends to appeal this ruling to the Supreme Court of Delaware.

Hillrom Comments On Delaware Court Of Chancery Ruling

ArcBest

Costco

Darling Ingredients

Darling Ingredients (DAR), Costco Wholesale (COST), HillRom Holdings (HRC) & ArcBest (ARCB) are the four best stocks that at present have striking earnings growth and positive estimate revisions.

4 Top Stocks That Flaunt Superb Earnings Growth

CHICAGO, July 8, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2021 fourth quarter dividend of $0.24 per share payable on September 30, 2021, to shareholders of record as of the close of business on September 17, 2021. The indicated annual dividend rate is $0.96 per share.

Hillrom Declares Fiscal 2021 Fourth Quarter Dividend

CHICAGO, July 6, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal third quarter 2021 earnings conference call and webcast on Friday, July 30, 2021, beginning at 7:30 a.m. (CT) / 8:30 a.m.

Hillrom To Host Fiscal Third Quarter 2021 Earnings Conference Call And Webcast

Hill-Rom Holdings presents as a deep-value proposition relative to peers and on a fair value basis. Given recent macro-thematics observed in global equity markets in FY2021, rotation back into value names has been a key alpha-driver.

Hill-Rom Holdings: Deep Value Proposition With ~35-40% Upside Potential Under-Reflected

Cintas Corp

FedEx

Polaris

Vertiv Holdings Co

Tech stocks like Apple, Facebook, Alphabet, and Amazon have all dropped again. But Q.ai's artificial intelligence systems have assessed each firm to find the best top buys.

Cintas Among Today's Top Buys As Tech Stocks Continue To Fall Behind

CHICAGO, May 10, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021. Barbara Bodem, Hillrom's SVP & Chief Financial Officer, will participate in a fireside chat at 10:00 a.m.

Hillrom to Present at the UBS Global Healthcare Virtual Conference

CHICAGO, May 4, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) announced today that its board of directors declared a fiscal 2021 third quarter dividend of $0.24 per share payable on June 30, 2021, to shareholders of record as of the close of business on June 18, 2021. The indicated annual dividend rate is $0.96 per share.

Hillrom Declares Fiscal 2021 Third Quarter Dividend

Hill-Rom's (HRC) second-quarter revenues improved year over year on continued recovery across all three business segments as well as expanded demand for critical care products.

Hill-Rom (HRC) Q2 Earnings Surpass Estimates, Margins Up

Hill-Rom Holdings, Inc. (HRC) CEO John Groetelaars on Q2 2021 Results - Earnings Call Transcript

Hill-Rom (HRC) delivered earnings and revenue surprises of 20.98% and 4.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Hill-Rom (HRC) Surpasses Q2 Earnings and Revenue Estimates

Hill-Rom (NYSE: HRC) reported Q2 Non-GAAP earnings rose 35% at $1.73 and exceeded the company's guidance range of $1.40 to $1.45 and surpassed analyst consensus of $1.43. GAAP earnings of $1.30 higher than $0.70 in the prior-year period.

Hill-Rom Q2 Earnings Exceed Expectations; Raises Fiscal 2021 Outlook

Shares of Hill-Rom Holdings (NYSE:HRC) moved higher by 1.2% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 35.16% year over year to $1.73, which beat the estimate of $1.43.

Hill-Rom Holdings: Q2 Earnings Insights

CHICAGO, April 30, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced financial results for its fiscal second quarter ended March 31, 2021, and raised its fiscal 2021 guidance. For the fiscal second quarter, Hillrom reported GAAP earnings of $1.30 per diluted share compared to $0.70 per diluted share in the prior-year period.

Hillrom's Fiscal Second Quarter Financial Results Exceed Guidance As Recovery Momentum Progresses Across Portfolio

CHICAGO, April 28, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced that it will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021. John Groetelaars, Hillrom's president and chief executive officer, will participate in a fireside chat at 9:30 a.m.

Hillrom to Present at the BofA Securities 2021 Virtual Health Care Conference

CHICAGO, April 21, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) today announced major technological advances to its market-leading physical assessment tools with the launch of the new Welch Allyn® PanOptic™ Plus Ophthalmoscope and the Welch Allyn® MacroView® Plus Otoscope. The new devices represent advancements that build on more than 100 years of the company's innovation in physical assessment tools and a new standard of care in exam rooms.

Hillrom Launches Digital Physical Assessment Innovations to Advance Connected Care™

CHICAGO, April 11, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intent to acquire Bardy Diagnostics, Inc. (BardyDx). On April 10, 2021, the Medicare Administrative Contractor (MAC), Novitas Solutions, published updated reimbursement rates applicable to the Current Procedural Terminology (CPT) codes 93241, 93243, 93245 and 93247 for the extended Holter cardiac monitoring category applicable to all of BardyDx's products and services.

Hillrom Comments on Recent Novitas Reimbursement Update

BioLife Solutions

HRC vs. BLFS: Which Stock Is the Better Value Option?

HRC or BLFS: Which Is the Better Value Stock Right Now?

Cantel Medical

LeMaitre Vascular

Masimo

Cantel (CMD), Hill-Rom (HRC), LeMaitre (LMAT) and Masimo (MASI) can prove to be prudent investment choices in the critical care industry of the MedTech sector.

4 Critical Care Device Stocks to Deflect the COVID-19 Curveball

CHICAGO, April 5, 2021 /PRNewswire/ -- Hillrom (NYSE: HRC) will host its fiscal second quarter 2021 earnings conference call and webcast on Friday, April 30, 2021, beginning at 7:30 a.m. (CT) / 8:30 a.m.

Hillrom To Host Fiscal Second Quarter 2021 Earnings Conference Call And Webcast

Invacare

McKesson

Here are some dirt-cheap MedTech value stocks - IVC, MCK, HRC - which are expected to provide long-term gains in 2021.

3 Beaten-Down MedTech Stocks to Scoop Up Amid the Pandemic

Owens & Minor

Let's take a look at the three MedTech stocks performing well lately, banking on a host of impressive developments.

Buy 3 MedTech Stocks That Are Outperforming S&P 500 in 2021

Meridian Bioscience

Grab these four top stocks, HRC, OMI, MCK and VIVO, which continue to show promise amid the pandemic and can turn out to be wise investment choices for 2021.

News for Hill-Rom Hlds Stock (HRC)